Developer docs
API playgroundTry for free, no card

Search company profiles

Cronos Group

Full company profile

uuid0000hdb

Namestring
Cronos Group
Legal namestring
Cronos Group Inc.
Company typeenum
Public
Founded yearint
2013
Descriptiontext

Cronos Group Inc. is a Canadian publicly traded cannabis company (NASDAQ: CRON; TSX: CRON), founded in 2013 and headquartered in Toronto. The company cultivates, manufactures, and markets cannabis and cannabis-derived products across recreational and medicinal channels in Canada, Israel, Germany, Australia, and the UK, with Netherlands expansion pending via the acquisition of CanAdelaar B.V. Its product portfolio spans flower, vapes, pre-rolls, gummies, and extracts under four primary consumer brands: Spinach (the #1 vape brand in Canada), Lord Jones (premium positioning), PEACE NATURALS, and LIT.

The company's underlying platform combines licensed cultivation (including a 50%-owned GrowCo facility expected to deliver a 70% flower capacity increase in 2026), proprietary product innovation (liquid diamonds at 98.1% THC, live resin caviar fusions), and a rare cannabinoids research program. Distribution relies on regulated retail intermediaries: Canadian provincial cannabis boards and retailers, Israeli pharmacies, and licensed medical channels in Europe and Oceania. Cronos also pursues vertical integration through supply chain control and brand-led product launches targeted at category leadership.

The business model is transaction-based cannabis product sales. Revenue mechanics are volume-driven, with prices set by provincial regulators and pharmacy channels in each market. Customer segments are split between adult-use recreational consumers (primary) and medicinal cannabis patients, both served through wholesale/distributor relationships rather than direct-to-consumer. The company maintains a debt-free balance sheet with $832M in cash and short-term investments following Altria's $1.8B strategic investment for a 41% stake in 2018-2019, providing capital for M&A, product development, and the recently announced US$50M share repurchase program.

Short descriptiontext

Cronos Group is a publicly traded Canadian cannabis company that cultivates, manufactures, and markets recreational and medicinal cannabis products across Canada, Israel, Germany, Australia, and the UK under brands including Spinach (#1 vape brand in Canada), Lord Jones, PEACE NATURALS, and LIT.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersToronto, Canada
HQ citystring
Toronto
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cannabis cultivation, cannabis manufacturing, consumer cannabis brands, medical cannabis products, adult-use cannabis
Industry2 codes
1Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail)
CodeCRANAFAGPrimaryYes
2Adult-Use (Recreational) Cannabis Delivery & Online Ordering
CodeCRANAGAHPrimaryNo
Product category
Cannabis Products
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Cannabis Product Sales
TypeTransaction Fee
Description

Cronos generates revenue primarily through the sale of recreational and medicinal cannabis products including flower, extracts, vapes, pre-rolls, and edibles under its portfolio brands (Spinach, Lord Jones, PEACE NATURALS, LIT) across Canada, Israel, Germany, Australia, and the UK.

globenewswire.com
2International Market Expansion
TypeTransaction Fee
Description

Revenue growth driven by expansion in international markets, particularly Israel and other non-excise-tax jurisdictions. Q1 2026 showed 40% revenue increase driven by higher cannabis flower sales in Israel and other international markets.

globenewswire.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1Spinach
Description

Primary consumer brand offering cannabis vape products, gummies, and flower; ranked as the number one vape brand in Canada

thecronosgroup.com
+3 more records
Core offering1 text field

Cronos Group cultivates, manufactures, and markets cannabis and cannabis-derived products for both medical and adult-use markets. The company sells a diversified portfolio of branded cannabis consumer goods (vapes, pre-rolls, gummies, dried flower, and concentrates) under its Spinach, Lord Jones, PEACE NATURALS, and LIT brands across Canada, Israel, Germany, Australia, the UK, and pending entry into the Netherlands.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Spinach brand achieved #1 market position in Canadian vape category
+3 more records
Product overview1 text field

Cronos Group is a global cannabis company operating a multi-brand consumer goods portfolio. The company offers cannabis products across Canada, Israel, Germany, Australia, and the UK through its portfolio brands: Spinach® (the #1 vape brand in Canada), PEACE NATURALS®, Lord Jones®, and LIT™. Products include vape devices, concentrates, pre-rolls, and gummies. The company recently expanded into Europe through the acquisition of CanAdelaar B.V., establishing presence in the Netherlands' adult-use cannabis market. Cronos focuses on scaling consumer goods products through R&D and innovation, with operations spanning cultivation, manufacturing, and marketing of cannabis and cannabis-derived products.

Product and service8 records
1Spinach®
CategoryCannabis Brand / Vape & Edibles Product Line
Description

Cannabis consumer brand offering vape products, gummies, and cannabis concentrates; positioned as the number one vape brand in Canada and serving adult recreational consumers.

2PEACE NATURALS®
CategoryCannabis Brand / Medicinal & Adult-Use
Description

Cannabis brand offering medicinal and adult-use cannabis products in Canada and Israel, targeting both medical patients and adult recreational consumers.

3Lord Jones®
CategoryCannabis Brand / Premium Adult-Use
Description

Premium cannabis brand available in Canada and Israel offering high-THC products including live resin pre-rolls and other premium formats targeting adult-use consumers.

4LIT™
CategoryCannabis Brand
Description

Cannabis consumer brand included in Cronos Group's international brand portfolio serving adult-use recreational consumers.

5Spinach PUFFERZ™ All-in-One Vape
CategoryCannabis Vape Product
Description

All-in-one cannabis vape featuring liquid diamonds with 98.1% THC content, palm-style hardware with dual ceramic coil, boost button, and battery meter; sold in three flavors to adult recreational consumers through Canadian provincial retailers.

6Lord Jones Live Resin Fusions™ Pre-Rolls
CategoryCannabis Pre-Roll Product
Description

Premium pre-rolls combining dried flower with pure live resin caviar, offering an elevated cannabis experience with high THC potency for adult-use consumers in Canada.

7SOURZ by Spinach Multipack Gummies
CategoryCannabis Edible Product
Description

Fully blasted cannabis gummies offered in new multipack formats as part of the Spinach® brand product line targeting adult recreational consumers.

8Spinach® Green Apple Seasonal Products
CategoryCannabis Seasonal Edible & Vape Product
Description

Limited-edition seasonal Spinach® Green Apple-flavored cannabis products including THC gummies and vape products for fall/Halloween season.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-12-09
Description

Cronos Group is acquiring CanAdelaar B.V., the largest cannabis company in the Netherlands and the only industrial-scale greenhouse cultivator among the 10 licensed producers in the Wietexperiment adult-use cannabis pilot program. Acquisition valued at US$67 million upfront plus contingent consideration based on 0.5x normalized EBITDA in 2026 and 2027. CanAdelaar generated US$47.3 million in revenue and US$28.2 million in EBITDA for the 12 months ended September 30, 2025.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Cronos holds 50% ownership in GrowCo, a cultivation facility. The company completed GrowCo expansion in 2025, with 70% flower capacity increase expected in 2026. GrowCo provides vertical integration and supply chain control for Cronos' product portfolio.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Canadian-headquartered, NASDAQ-listed multi-brand cannabis operator with overlapping brand portfolio (Broken Coast, Redecan, Hi-Ball), international footprint (Germany, Australia, UK), and a broader CPG pivot strategy directly comparable to Cronos's multi-brand, multi-geography model.

TypeDirect peer
Description

Largest Canadian cannabis producer (NASDAQ: CGC, TSX: WEED) with brand portfolio including Tweed, Spectrum Therapeutics, and Storz & Bickel. Competes directly with Cronos in Canadian recreational and international medical channels and shares the same multi-brand, multi-jurisdiction regulatory complexity.

TypeDirect peer
Description

Canadian-licensed producer (NASDAQ: ACB, TSX: ACB) focused on medical cannabis globally (Germany, Australia, UK) and Canadian adult-use. Direct overlap with Cronos's Israeli/European medical strategy and Canadian retail competition.

TypeDirect peer
Description

Canadian LP (NASDAQ: OGI, TSX: OGI) producing dried flower, pre-rolls, vapes, and edibles under brands like SHRED and BIG BUD PRESS. Direct competitor in Canadian recreational flower/vape categories alongside Cronos's Spinach brand.

TypeDirect peer
Description

Canadian cannabis producer and retailer (NASDAQ: SNDL) operating retail via Value Buds and cannabis cultivation through several brands. Comparable to Cronos as a publicly-traded Canadian operator with both cultivation and downstream retail exposure.

TypeDirect peer
Description

US multi-state operator (CSE: CURA) with national retail footprint and branded cannabis products. Comparable as a multi-brand, multi-jurisdiction cannabis CPG platform, though US-focused versus Cronos's Canada/Israel/Europe orientation.

TypeDirect peer
Description

US MSO (CSE: GTII) operating Rise and Essence dispensaries plus branded products. Comparable as a vertically-integrated multi-brand cannabis platform with CPG-style brand portfolio approach.

TypeDirect peer
Description

US MSO (CSE: TRUL) with extensive state-by-state retail and branded product lines. Comparable to Cronos as a public, multi-state/multi-brand cannabis operator pursuing CPG-like scale.

TypeOthers
Description

Calgary-based cannabis retailer (NASDAQ: HITI) operating Canna Cabana stores with 2.5M loyalty members; Cronos holds a strategic investment in High Tide as part of its retail independence strategy, making it a channel partner and minor investee rather than a direct cultivation competitor.

TypeBroad incumbent
Description

US tobacco incumbent and Cronos's largest shareholder (~41% stake from a US$1.8B 2019 investment). Not a cannabis operator but the most consequential strategic stakeholder shaping Cronos's access to capital, CPG expertise, and potential regulated-product adjacencies.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment3 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cronos Group

Cannabis Productsthecronosgroup.com

Cronos Group is a publicly traded Canadian cannabis company that cultivates, manufactures, and markets recreational and medicinal cannabis products across Canada, Israel, Germany, Australia, and the UK under brands including Spinach (#1 vape brand in Canada), Lord Jones, PEACE NATURALS, and LIT.

What Cronos Group does

Cronos Group Inc. is a Canadian publicly traded cannabis company (NASDAQ: CRON; TSX: CRON), founded in 2013 and headquartered in Toronto. The company cultivates, manufactures, and markets cannabis and cannabis-derived products across recreational and medicinal channels in Canada, Israel, Germany, Australia, and the UK, with Netherlands expansion pending via the acquisition of CanAdelaar B.V. Its product portfolio spans flower, vapes, pre-rolls, gummies, and extracts under four primary consumer brands: Spinach (the #1 vape brand in Canada), Lord Jones (premium positioning), PEACE NATURALS, and LIT.

The company's underlying platform combines licensed cultivation (including a 50%-owned GrowCo facility expected to deliver a 70% flower capacity increase in 2026), proprietary product innovation (liquid diamonds at 98.1% THC, live resin caviar fusions), and a rare cannabinoids research program. Distribution relies on regulated retail intermediaries: Canadian provincial cannabis boards and retailers, Israeli pharmacies, and licensed medical channels in Europe and Oceania. Cronos also pursues vertical integration through supply chain control and brand-led product launches targeted at category leadership.

The business model is transaction-based cannabis product sales. Revenue mechanics are volume-driven, with prices set by provincial regulators and pharmacy channels in each market. Customer segments are split between adult-use recreational consumers (primary) and medicinal cannabis patients, both served through wholesale/distributor relationships rather than direct-to-consumer. The company maintains a debt-free balance sheet with $832M in cash and short-term investments following Altria's $1.8B strategic investment for a 41% stake in 2018-2019, providing capital for M&A, product development, and the recently announced US$50M share repurchase program.

Cronos Group firmographics

Firmographics
Name
Cronos Group
Legal name
Cronos Group Inc.
Website
https://thecronosgroup.com
Company type
Public
Founded year
2013
Operating status
Operating
Headcount range
251–500 employees
Short description
Cronos Group is a publicly traded Canadian cannabis company that cultivates, manufactures, and markets recreational and medicinal cannabis products across Canada, Israel, Germany, Australia, and the UK under brands including Spinach (#1 vape brand in Canada), Lord Jones, PEACE NATURALS, and LIT.
Ownership category
akta.pro rank

Cronos Group industry classification

Industry
Product category
Cannabis Products
akta.pro primary industry
Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail) (CRANAFAG)
akta.pro secondary industry
Adult-Use (Recreational) Cannabis Delivery & Online Ordering (CRANAGAH)

Keywords

  • Cannabis cultivation
  • Cannabis manufacturing
  • Consumer cannabis brands
  • Medical cannabis products
  • Adult-use cannabis

Where Cronos Group is headquartered

Location

Headquarters

HQ city
Toronto
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Cronos Group business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Cannabis Product Sales: Cronos generates revenue primarily through the sale of recreational and medicinal cannabis products including flower, extracts, vapes, pre-rolls, and edibles under its portfolio brands (Spinach, Lord Jones, PEACE NATURALS, LIT) across Canada, Israel, Germany, Australia, and the UK.
  2. International Market Expansion: Revenue growth driven by expansion in international markets, particularly Israel and other non-excise-tax jurisdictions. Q1 2026 showed 40% revenue increase driven by higher cannabis flower sales in Israel and other international markets.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Cronos Group product offering

Product offering

Core offering

Cronos Group cultivates, manufactures, and markets cannabis and cannabis-derived products for both medical and adult-use markets. The company sells a diversified portfolio of branded cannabis consumer goods (vapes, pre-rolls, gummies, dried flower, and concentrates) under its Spinach, Lord Jones, PEACE NATURALS, and LIT brands across Canada, Israel, Germany, Australia, the UK, and pending entry into the Netherlands.

Product overview

Cronos Group is a global cannabis company operating a multi-brand consumer goods portfolio. The company offers cannabis products across Canada, Israel, Germany, Australia, and the UK through its portfolio brands: Spinach® (the #1 vape brand in Canada), PEACE NATURALS®, Lord Jones®, and LIT™. Products include vape devices, concentrates, pre-rolls, and gummies. The company recently expanded into Europe through the acquisition of CanAdelaar B.V., establishing presence in the Netherlands' adult-use cannabis market. Cronos focuses on scaling consumer goods products through R&D and innovation, with operations spanning cultivation, manufacturing, and marketing of cannabis and cannabis-derived products.

Differentiator

Problem solved

Functional benefit

Brands

  • Spinach: Primary consumer brand offering cannabis vape products, gummies, and flower; ranked as the number one vape brand in Canada
  • PEACE NATURALS
  • LIT
  • Lord Jones

Products and services

  • Spinach® Cannabis consumer brand offering vape products, gummies, and cannabis concentrates; positioned as the number one vape brand in Canada and serving adult recreational consumers.
  • PEACE NATURALS® Cannabis brand offering medicinal and adult-use cannabis products in Canada and Israel, targeting both medical patients and adult recreational consumers.
  • Lord Jones® Premium cannabis brand available in Canada and Israel offering high-THC products including live resin pre-rolls and other premium formats targeting adult-use consumers.
  • LIT™ Cannabis consumer brand included in Cronos Group's international brand portfolio serving adult-use recreational consumers.
  • Spinach PUFFERZ™ All-in-One Vape All-in-one cannabis vape featuring liquid diamonds with 98.1% THC content, palm-style hardware with dual ceramic coil, boost button, and battery meter; sold in three flavors to adult recreational consumers through Canadian provincial retailers.
  • Lord Jones Live Resin Fusions™ Pre-Rolls Premium pre-rolls combining dried flower with pure live resin caviar, offering an elevated cannabis experience with high THC potency for adult-use consumers in Canada.
  • SOURZ by Spinach Multipack Gummies Fully blasted cannabis gummies offered in new multipack formats as part of the Spinach® brand product line targeting adult recreational consumers.
  • Spinach® Green Apple Seasonal Products Limited-edition seasonal Spinach® Green Apple-flavored cannabis products including THC gummies and vape products for fall/Halloween season.

Quantifiable outcome

  • Spinach brand achieved #1 market position in Canadian vape category
  • +3 more outcomes

Companies that use Cronos Group

Customer profile

Segments3 records

Ideal customer profiles3 records

Cronos Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Cronos Group partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered flagship and core.

  • CanAdelaar B.V.flagshipStrategic or Co-development Partner · 9 December 2025Cronos Group is acquiring CanAdelaar B.V., the largest cannabis company in the Netherlands and the only industrial-scale greenhouse cultivator among the 10 licensed producers in the Wietexperiment adult-use cannabis pilot program. Acquisition valued at US$67 million upfront plus contingent consideration based on 0.5x normalized EBITDA in 2026 and 2027. CanAdelaar generated US$47.3 million in revenue and US$28.2 million in EBITDA for the 12 months ended September 30, 2025.
  • GrowCocoreStrategic or Co-development PartnerCronos holds 50% ownership in GrowCo, a cultivation facility. The company completed GrowCo expansion in 2025, with 70% flower capacity increase expected in 2026. GrowCo provides vertical integration and supply chain control for Cronos' product portfolio.

Scale indicators8 records

Recent moves8 records

Expansion highlights6 records

Cronos Group competitors and assessment

Company assessment

Direct peers

  • Tilray Brands: Canadian-headquartered, NASDAQ-listed multi-brand cannabis operator with overlapping brand portfolio (Broken Coast, Redecan, Hi-Ball), international footprint (Germany, Australia, UK), and a broader CPG pivot strategy directly comparable to Cronos's multi-brand, multi-geography model.
  • Canopy Growth Corporation: Largest Canadian cannabis producer (NASDAQ: CGC, TSX: WEED) with brand portfolio including Tweed, Spectrum Therapeutics, and Storz & Bickel. Competes directly with Cronos in Canadian recreational and international medical channels and shares the same multi-brand, multi-jurisdiction regulatory complexity.
  • Aurora Cannabis: Canadian-licensed producer (NASDAQ: ACB, TSX: ACB) focused on medical cannabis globally (Germany, Australia, UK) and Canadian adult-use. Direct overlap with Cronos's Israeli/European medical strategy and Canadian retail competition.
  • OrganiGram Holdings: Canadian LP (NASDAQ: OGI, TSX: OGI) producing dried flower, pre-rolls, vapes, and edibles under brands like SHRED and BIG BUD PRESS. Direct competitor in Canadian recreational flower/vape categories alongside Cronos's Spinach brand.
  • SNDL Inc. Canadian cannabis producer and retailer (NASDAQ: SNDL) operating retail via Value Buds and cannabis cultivation through several brands. Comparable to Cronos as a publicly-traded Canadian operator with both cultivation and downstream retail exposure.
  • Curaleaf Holdings: US multi-state operator (CSE: CURA) with national retail footprint and branded cannabis products. Comparable as a multi-brand, multi-jurisdiction cannabis CPG platform, though US-focused versus Cronos's Canada/Israel/Europe orientation.
  • Green Thumb Industries: US MSO (CSE: GTII) operating Rise and Essence dispensaries plus branded products. Comparable as a vertically-integrated multi-brand cannabis platform with CPG-style brand portfolio approach.
  • Trulieve Cannabis: US MSO (CSE: TRUL) with extensive state-by-state retail and branded product lines. Comparable to Cronos as a public, multi-state/multi-brand cannabis operator pursuing CPG-like scale.

Others

  • High Tide: Calgary-based cannabis retailer (NASDAQ: HITI) operating Canna Cabana stores with 2.5M loyalty members; Cronos holds a strategic investment in High Tide as part of its retail independence strategy, making it a channel partner and minor investee rather than a direct cultivation competitor.

Broad incumbents

  • Altria Group: US tobacco incumbent and Cronos's largest shareholder (~41% stake from a US$1.8B 2019 investment). Not a cannabis operator but the most consequential strategic stakeholder shaping Cronos's access to capital, CPG expertise, and potential regulated-product adjacencies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks4 records

Customer concentration

Cronos Group social profiles

Digital presence

Cronos Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cronos Group leadership team

Management profile

Number of profiles

Profiles7 records

Cronos Group subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Cronos Group funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cronos Group M&A and investment

M&A and investment

M&A3 records

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cronos Group

What does Cronos Group do?

Cronos Group cultivates, manufactures, and markets cannabis and cannabis-derived products for both medical and adult-use markets. The company sells a diversified portfolio of branded cannabis consumer goods (vapes, pre-rolls, gummies, dried flower, and concentrates) under its Spinach, Lord Jones, PEACE NATURALS, and LIT brands across Canada, Israel, Germany, Australia, the UK, and pending entry into the Netherlands.

Is Cronos Group a public or private company?

Cronos Group is a public company. It is classified as public and is currently operating.

When was Cronos Group founded?

Cronos Group was founded in 2013. It employs 251 to 500 people.

Where is Cronos Group based?

Cronos Group is headquartered in Toronto, Canada, in the North America region.

How does Cronos Group make money?

Two revenue lines are on record. Cannabis Product Sales are the primary driver. The others are international Market Expansion.

Who are Cronos Group's main competitors?

Direct peers on record are Tilray Brands, Canopy Growth Corporation, Aurora Cannabis, OrganiGram Holdings, SNDL Inc., Curaleaf Holdings, Green Thumb Industries and Trulieve Cannabis. High Tide is listed as an others. Altria Group is listed as a broad incumbent.

Does Cronos Group have an API?

No public API is recorded for Cronos Group.

What industry is Cronos Group in?

Cronos Group's product category is Cannabis Products. Its primary akta.pro industry code is CRANAFAG, Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail), with a secondary code of CRANAGAH, Adult-Use (Recreational) Cannabis Delivery & Online Ordering.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
American Banking and Market NewsCronos Group Inc. (NASDAQ:CRON) Stock Now Rated “Moderate Buy” by Wall Street AnalystsCronos Group shares received a consensus "Moderate Buy" rating from five analysts, with an average price target of $2.30. The company reported Q2 EPS of $0.09, beating estimates, and revenue of $53.01 million. Institutional investors increased stakes, including Squarepoint and Amundi.MarketWatchCronos Group Inc. stock rises Tuesday, outperforms marketCronos Group Inc. shares rose on Tuesday, marking a third consecutive day of gains. The stock closed 8.94% below its 52-week high of $3.61, reached on August 27th, with trading volume 574,405 below the 50-day average.Defense WorldCronos Group Inc. $CRON Shares Newly Acquired by Bank of America Corp DEBank of America Corp DE acquired a new stake in Cronos Group, buying 157,631 shares worth about $438,000 in Q2. Cronos reported Q2 EPS of $0.09, beating estimates, with revenue of $53.01 million. Analysts rate the stock a Moderate Buy with a $2.30 price target.AInvestWhy Is CRON Stock Rising Today? Cronos Group Surges 13% After Earnings BeatCronos Group shares rose 13.17% pre-market after reporting Q3 EPS of $0.09, an 800% beat on a $0.01 estimate, with revenue up 58% to $53 million. The company held $827 million in cash and repurchased 12.3 million shares. The CanAdelaar acquisition deadline is extended to October 15, 2026.Defense WorldContrasting Cronos Group (NASDAQ:CRON) and Takeda Pharmaceutical (NYSE:TAK)Cronos Group and Takeda Pharmaceutical are compared on institutional ownership, analyst ratings, earnings, dividends, profitability, valuation, and risk. Cronos has lower revenue but higher earnings and a lower P/E ratio, with a consensus target price of $2.30 implying 31.14% downside. Cronos is favored by analysts for higher upside.Ticker ReportFinancial Contrast: Cronos Group (NASDAQ:CRON) vs. Theravance Biopharma (NASDAQ:TBPH)Theravance Biopharma and Cronos Group are compared on profitability, risk, and analyst ratings. Cronos Group has higher revenue but lower earnings, while Theravance Biopharma shows higher net margins and a lower beta. Analysts rate Cronos Group more favorably, with a consensus price target of $2.30 versus $19.40 for Theravance.Simply Wall StCronos Group Stock Leads 3 Canadian Penny Stocks To WatchCronos Group, Omai Gold Mines, and McChip Resources are highlighted as financially fit Canadian penny stocks. Cronos generates about $179 million in revenue with a market cap near $1.8 billion, while Omai and McChip have market caps around $1.9 billion and $4 million respectively.PR NewswireLabaton Keller Sucharow LLP Announces a Proposed Settlement in the Cronos U.S. Securities SettlementLabaton Keller Sucharow LLP announced a proposed $10 million settlement in the Cronos Group U.S. securities class action. The settlement would release claims and extinguish future recovery, with a hearing set for November 19, 2026. Class members must submit claims by November 9, 2026.NewswireLabaton Keller Sucharow LLP Announces a Proposed Settlement in the Cronos U.S. Securities SettlementLabaton Keller Sucharow LLP announced a proposed $10 million settlement in the Cronos Group U.S. securities class action. The settlement would release claims and extinguish future recovery, with a hearing set for November 19, 2026. Class members must submit claims by November 9, 2026.The Motley Fool2 Cannabis Stocks That Are Quietly Trouncing the Market in 2026Trulieve and Cronos Group have each gained about 27% through Sept. 18, outpacing the S&P 500's 12% gain. Trulieve reported Q2 revenue of $271 million and $109 million operating cash flow, while Cronos saw Q2 net revenue jump 58% to $53 million. Both companies hold substantial cash reserves and show improving financial performance.